Genmab A/S (Genmab) is a biotechnology company focused on the research and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company uses its cutting-edge technology to create and develop products to address unmet medical needs of oncology, infectious diseases, rheumatoid arthritis and other inflammatory conditions. Genmab focuses on building a broad portfolio of new therapeutic products, while many of its product candidates for the treatment of cancer are in development phases. The company is headquartered at Copenhagen, Denmark.

Synopsis

The 'Genmab A/S: Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Scope

• Examines and identifies key information and issues about 'Genmab A/S' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios of the company
• The profile also contains information on business operations, company history, major products and services, prospects, key competitors, key employees, locations and subsidiaries

Reasons To Buy

• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Increase business/sales activities by understanding your competitors' businesses better
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures

Click for Report details:Genmab A/S: Company Profile and SWOT Analysis